Literature DB >> 3455845

RCH-ACV: a lymphoblastic leukemia cell line with chromosome translocation 1;19 and trisomy 8.

I Jack, R Seshadri, M Garson, P Michael, D Callen, H Zola, A Morley.   

Abstract

A cell line (RCH-ACV) was established from a bone marrow sample of a child with acute lymphoblastic leukemia (ALL). The cell line lacked Epstein-Barr virus nuclear antigen and exhibited a recently described nonrandom chromosome translocation, 1;19, thought to be associated with pre-B-ALL and poor prognosis. Banding studies confirm that the breakpoint of chromosome #19 occurs at p13.3. Cell surface marker analysis using a panel of monoclonal antibodies revealed markers consistent with common ALL phenotype. Although the cells did not show cytoplasmic immunoglobulin, studies of the immunoglobulin gene rearrangement confirmed the pre-B phenotype. This cell line could be of great value to studies of the role of the specific translocation 1;19 in the etiology of pre-B-ALL.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3455845     DOI: 10.1016/0165-4608(86)90055-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  13 in total

1.  Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias.

Authors:  S Ziemin-van der Poel; N R McCabe; H J Gill; R Espinosa; Y Patel; A Harden; P Rubinelli; S D Smith; M M LeBeau; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia.

Authors:  Jesús Duque-Afonso; Chiou-Hong Lin; Kyuho Han; David W Morgens; Edwin E Jeng; Ziming Weng; Johan Jeong; Stephen Hon Kit Wong; Li Zhu; Michael C Wei; Hee-Don Chae; Martin Schrappe; Gunnar Cario; Justus Duyster; Xiangshu Xiao; Kathleen M Sakamoto; Michael C Bassik; Michael L Cleary
Journal:  Cancer Res       Date:  2018-09-27       Impact factor: 12.701

3.  Cell Surface Proteomics of N-Linked Glycoproteins for Typing of Human Lymphocytes.

Authors:  Nicole A Haverland; Matthew Waas; Ioanna Ntai; Theodore Keppel; Rebekah L Gundry; Neil L Kelleher
Journal:  Proteomics       Date:  2017-10       Impact factor: 3.984

4.  Molecular analysis of TCRB and ABL in a t(7;9)-containing cell line (SUP-T3) from a human T-cell leukemia.

Authors:  C A Westbrook; C M Rubin; M M Le Beau; L S Kaminer; S D Smith; J D Rowley; M O Diaz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  Adipocytes impair leukemia treatment in mice.

Authors:  James W Behan; Jason P Yun; Marina P Proektor; Ehsan A Ehsanipour; Anna Arutyunyan; Ara S Moses; Vassilios I Avramis; Stan G Louie; Anna Butturini; Nora Heisterkamp; Steven D Mittelman
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

6.  Development of a single-cell array for large-scale DNA fluorescence in situ hybridization.

Authors:  Yingru Liu; Brett Kirkland; James Shirley; Zhibin Wang; Peipei Zhang; Jacquelyn Stembridge; Wilson Wong; Shin-ichiro Takebayashi; David M Gilbert; Steven Lenhert; Jingjiao Guan
Journal:  Lab Chip       Date:  2013-04-07       Impact factor: 6.799

7.  Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations.

Authors:  N R McCabe; R C Burnett; H J Gill; M J Thirman; D Mbangkollo; M Kipiniak; E van Melle; S Ziemin-van der Poel; J D Rowley; M O Diaz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis.

Authors:  Rolf I Skotheim; Gard O S Thomassen; Marthe Eken; Guro E Lind; Francesca Micci; Franclim R Ribeiro; Nuno Cerveira; Manuel R Teixeira; Sverre Heim; Torbjørn Rognes; Ragnhild A Lothe
Journal:  Mol Cancer       Date:  2009-01-19       Impact factor: 27.401

9.  Fc receptor gene translocation in a t(1;19) pre-B ALL cell line.

Authors:  L M Webber; O M Garson; B Tate; I F McKenzie; P M Hogarth
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

10.  RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.

Authors:  Adam C Wilkinson; Erica Ballabio; Huimin Geng; Phillip North; Marta Tapia; Jon Kerry; Debabrata Biswas; Robert G Roeder; C David Allis; Ari Melnick; Marella F T R de Bruijn; Thomas A Milne
Journal:  Cell Rep       Date:  2013-01-24       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.